WHAT MAKES REVANESSE® VERSA™ UNIQUE?
LESS SWELLING
In one of our clinical trials, 50% more patients treated with a comparative product experienced swelling, than patients who were treated with Revanesse® Versa™. 1
LONGEVITY You may find that Revanesse® Versa™ will help in the improvement of your nasolabial folds (laugh lines) for up to 12 months with optimal correction. 2
DESIGNED FOR SAFETY The Revanesse® Versa™ formula is well-studied, with over 300 patients of multiple skin types, treated in three clinical trials, with no serious adverse events reported.
IMMEDIATE RESULTS A Revanesse® Versa™ treatment is minimally invasive and provides immediate results. Take control of the signs of aging and ask your healthcare provider if Revanesse® Versa™ is right for you.
1 Injection site swelling (47.2% [77/163] with Revanesse® Versa™, 71.1% [116/163] with Comparator) 2 Multicenter Study to Evaluate the Safety and Efficacy of Revanesse Ultra Retreatment 78.1% of subjects reported being improved, much improved, or very much improved at 52 weeks according to their pGAI scores.
LONGEVITY You may find that Revanesse® Versa™ will help in the improvement of your nasolabial folds (laugh lines) for up to 12 months with optimal correction. 2
DESIGNED FOR SAFETY The Revanesse® Versa™ formula is well-studied, with over 300 patients of multiple skin types, treated in three clinical trials, with no serious adverse events reported.
IMMEDIATE RESULTS A Revanesse® Versa™ treatment is minimally invasive and provides immediate results. Take control of the signs of aging and ask your healthcare provider if Revanesse® Versa™ is right for you.
1 Injection site swelling (47.2% [77/163] with Revanesse® Versa™, 71.1% [116/163] with Comparator) 2 Multicenter Study to Evaluate the Safety and Efficacy of Revanesse Ultra Retreatment 78.1% of subjects reported being improved, much improved, or very much improved at 52 weeks according to their pGAI scores.
THE NEW 1.2ML SYRINGE
A LITTLE MORE GOES A LONG WAY Revanesse® Versa™ is the only hyaluronic acid (HA) dermal filler in the US available in a 1.2mL syringe size.Whether you require more product to be brought to full correction or are seeking a more cost-effective treatment option; 20% more product in our syringe is another example of the Revanesse® difference and our commitment to providing pathways for patients to achieve the best possible results.
INJECTION DEPTH
Revanesse® Versa™ is indicated for injection into the mid to deep dermis for correction of moderate to severe facial wrinkles and folds, such as nasolabial folds, in adults 22 years of age or more.THE NEW LIP FILLER ON THE BLOCK
PHYSICIAN BACKED
100% of treating Physicians rated the Revanesse® Lips™+ subjects as improved, much improved, or very much improved at 6 months vs. 76.4% for those treated with the comparator.1
PATIENT BACKED 96.3% of Revanesse® Lips™+ subjects rated themselves as improved, much improved, or very much improved at 6 months vs. 83.6% who were treated with the comparator.
MINIMAL DOWNTIME There were no unexpected product-related side effects with a Revanesse® Lips™+ treatment. 1
LESS PAIN Fewer subjects reported pain with their Revanesse® Lips™+ treatment.1
LESS PRODUCT REQUIRED On average Revanesse® Lips™+ required less volume to achieve optimal treatment outcomes.1
MINIMAL SWELLING 98.1% of patients treated with Revanesse® Lips™+ reported to have minimal or no swelling after their first treatment.2
1 Revanesse® Lips™+ Instructions for Use, Prollenium Medical Technologies, Inc. 2020 2 Revanesse® Lips™+ Instructions for Use, Prollenium Medical Technologies, Inc. 2020. Swelling was assessed at visits 2, 3, 4, and 5, not on visit 1. At visit 2/month 1, subjects were evaluated by the investigator and their swelling was assessed on a scale of 0 (none) to 4 (severe).
PATIENT BACKED 96.3% of Revanesse® Lips™+ subjects rated themselves as improved, much improved, or very much improved at 6 months vs. 83.6% who were treated with the comparator.
MINIMAL DOWNTIME There were no unexpected product-related side effects with a Revanesse® Lips™+ treatment. 1
LESS PAIN Fewer subjects reported pain with their Revanesse® Lips™+ treatment.1
LESS PRODUCT REQUIRED On average Revanesse® Lips™+ required less volume to achieve optimal treatment outcomes.1
MINIMAL SWELLING 98.1% of patients treated with Revanesse® Lips™+ reported to have minimal or no swelling after their first treatment.2
1 Revanesse® Lips™+ Instructions for Use, Prollenium Medical Technologies, Inc. 2020 2 Revanesse® Lips™+ Instructions for Use, Prollenium Medical Technologies, Inc. 2020. Swelling was assessed at visits 2, 3, 4, and 5, not on visit 1. At visit 2/month 1, subjects were evaluated by the investigator and their swelling was assessed on a scale of 0 (none) to 4 (severe).
BEFORE / AFTER
Actual patient treated with 1.2mL. Individual results may vary and might require multiple treatment sessions.
Actual patient treated with 1.2mL. Individual results may vary and might require multiple treatment sessions.
BEFORE / AFTER
Actual patient treated with 1.2mL. Individual results may vary and might require multiple treatment sessions.
Actual patient treated with 1.2mL. Individual results may vary and might require multiple treatment sessions.
